AptarGroup, Inc. (ATR) Stock Score, Valuation & Financial Research
AptarGroup, Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 39/100.
Quick answer for ATR
AptarGroup, Inc. currently has a Wall Street Score of 39/100. The stored market price is $123.05. Its financial score is 37/100. Its valuation score is 16/100. These figures are a research snapshot, not a buy or sell recommendation.
What AptarGroup, Inc. does
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with
ATR financial snapshot
- Wall Street Score:
- 39/100
- Current price:
- $123.05
- Market capitalization:
- $7.85B
- Revenue:
- $3.93B
- Net income:
- $362.5M
- Free cash flow:
- $299.6M
- Cash:
- $190.4M
- Total debt:
- $1.43B
- EPS:
- 5.60
- P/E ratio:
- 22.0x
- Financial score:
- 37/100
- Valuation score:
- 16/100
- Revenue score:
- 21/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $299.6M, showing positive cash generation.
- The balance sheet shows $190.4M of cash versus $1.43B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 37/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-09.
How to research ATR
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.